EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevalence of OATP1B ‐Mediated Drug–Drug Interactions in an Academic Medical Center

Mathilde Bories iD, David Malnoë iD, Pascal Le Corre iD

Clinical and Translational Science · 2025-06 · 18 (6)

DOI: 10.1111/cts.70260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 04.06.2025. Verfasst von Mathilde Bories und 2 weiteren Autor:innen. Beteiligte Einrichtung: CHU Rennes, INSERM, LTSI-UMR 1099, Univ Rennes, Rennes, France. Hauptthemen laut MEDLINE: Liver-Specific Organic Anion Transporter 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OATP1B is a key transporter involved in hepatic drug uptake, where its inhibition can significantly increase plasma drug levels, leading to potential adverse effects. This retrospective study aimed to determine the prevalence of potential drug–drug interactions (pDDIs) mediated by the hepatic transporter OATP1B1/3 in a cohort of 44,877 patients hospitalized at Rennes Academic Medical Center, using data from the Clinical Data Warehouse. We analyzed prescription rates of OATP1B substrates and inhibitors and estimated the prevalence of pDDIs, assessed the consistency of pDDI identification across different drug interaction databases, and performed a literature review of identified OATP1B‐based pDDIs. The identification of pDDIs across different drug databases showed inconsistencies, with limited overlap and variability in reported interactions. Among hospitalized patients, 6954 (15.5%) received OATP1B substrates, while 408 (0.9%) received inhibitors, leading to 106 pDDIs observed in 99 patients (0.2%). The pDDI rate varied significantly depending on the inhibitor used, reaching up to 39.1% in patients treated with ciclosporin. Statins accounted for a large proportion of pDDIs, emphasizing the potential risks, especially in multidrug regimens. Commonly involved inhibitors included FDA drugs such as ciclosporin, clarithromycin, and rifampicin. The clinical relevance of these interactions remains uncertain due to the limited availability of supporting evidence and the restricted list of well‐characterized OATP1B substrates and inhibitors. This study highlights the complexity of OATP1B‐mediated pDDIs and the need for increased clinical awareness and further research to improve the detection and characterization of such pDDIs, particularly for high‐risk drugs with a narrow therapeutic index.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver-Specific Organic Anion Transporter 1HumansDrug InteractionsAcademic Medical CentersRetrospective StudiesMaleFemalePrevalenceMiddle AgedSolute Carrier Organic Anion Transporter Family Member 1B3AgedAdult

Stichwörter der Autor:innen

OATP1Bclinical data warehousedrug–drug‐interactiontransporter

Substanzen

Liver-Specific Organic Anion Transporter 1SLCO1B1 protein, humanSolute Carrier Organic Anion Transporter Family Member 1B3SLCO1B3 protein, human

Autor:innen und Institutionen

  • CHU Rennes, INSERM, LTSI-UMR 1099, Univ Rennes, Rennes, France.
  • Pôle Pharmacie, Secteur Pharmacotechnie et Onco-Pharmacie, Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Laboratoire de Biopharmacie et Pharmacie Clinique, Faculté de Pharmacie, Université de Rennes, Rennes, France.
  • Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Université de Rennes, Rennes, France.

ORCID-Profile: Mathilde Bories, David Malnoë, Pascal Le Corre

Zitieren

APA

Bories, M., Malnoë, D., & Le Corre, P. (2025). Prevalence of OATP1B ‐Mediated Drug–Drug Interactions in an Academic Medical Center. Clinical and Translational Science, 18(6). https://doi.org/10.1111/cts.70260

Vancouver

Bories M, Malnoë D, Le Corre P. Prevalence of OATP1B ‐Mediated Drug–Drug Interactions in an Academic Medical Center. Clinical and Translational Science. 2025;18(6). doi:10.1111/cts.70260

BibTeX
@article{Bories2025,
  author = {Bories, Mathilde and Malnoë, David and Le Corre, Pascal},
  title = {Prevalence of OATP1B ‐Mediated Drug–Drug Interactions in an Academic Medical Center},
  journal = {Clinical and Translational Science},
  year = {2025},
  volume = {18},
  number = {6},
  doi = {10.1111/cts.70260}
}
Kostenlos starten →